Statement of Principles concerning malignant neoplasm of the cervix No. 42 of 1997

Administered by Department of Veterans' Affairs

Legislation au F2008B00581 Not in force Legislative Instrument

Legislation content

Instrument No.42 of 1997

 

Revocation and Determination

of

Statement of Principles

concerning

 

MALIGNANT NEOPLASM OF THE CERVIX

 

ICD CODES: 180, 233.1

 

Veterans’ Entitlements Act 1986

 

 

1. The Repatriation Medical Authority under subsection 196B(3) of the Veterans’ Entitlements Act 1986 (the Act):

 

(a) revokes Instrument No. 128 of 1995; and

 

(b) determines the following Statement of Principles.

 

Kind of injury, disease or death

2. (a) This Statement of Principles is about malignant neoplasm of the cervix and death from malignant neoplasm of the cervix

 

(b) For the purposes of this Statement of Principles, “malignant neoplasm of the cervix” means a primary invasive carcinoma or carcinoma in situ (also known as cervical intraepithelial neoplasia grade III), arising from the cells of the cervix uteri, attracting ICD code 180 or 233.1

 

Note: For the purposes of this Statement of Principles, this definition specifically excludes soft tissue sarcoma, non-Hodgkin's lymphoma and Hodgkin's disease.

 

Note to user (this note does not form part of the legal wording of the instrument):

 

In the event that a disease referred to in the note above (which is excluded from coverage by this Statement of Principles) is claimed, reference should be made to the relevant Statement of Principles (or Statements of Principles) which cover or refer to that disease (if any).

 

Basis for determining the factors

3. On the sound medical-scientific evidence available, the Repatriation Medical Authority is of the view that it is more probable than not that malignant neoplasm of the cervix and death from malignant neoplasm of the cervix can be related to relevant service rendered by veterans or members of the Forces.

 

Factors that must be related to service

4. Subject to clause 6, the factors set out in at least one of the paragraphs in clause 5 must be related to any relevant service rendered by the person.

 

Factors

5. The factors that must exist before it can be said that, on the balance of probabilities, malignant neoplasm of the cervix or death from  malignant neoplasm of the cervix is connected with the circumstances of a person’s relevant service are:

 

(a) using the combined oral contraceptive pill for a period of at least six years, and, where use of the combined oral contraceptive pill has ceased, the clinical onset of malignant neoplasm of the cervix has occurred within five years of cessation; or

 

(b) smoking at least 10 pack-years of cigarettes, or smoking the equivalent thereof in other tobacco products, before the clinical onset of malignant neoplasm of the cervix, and, where smoking has ceased, the clinical onset has occurred within 10 years of cessation; or

 

(c) being infected with genital human papilloma virus (HPV) of the cervical epithelium before the clinical onset of malignant neoplasm of the cervix; or

 

(d) being infected with human immunodeficiency virus (HIV), with evidence of immunosuppression, at the time of the clinical onset of malignant neoplasm of the cervix; or

 

(e) receiving chronic systemic immunosuppressive drug therapy at the time of the clinical onset of malignant neoplasm of the cervix; or

 

(f) being infected with human immunodeficiency virus (HIV), with evidence of immunosuppression at the time of the clinical worsening of malignant neoplasm of the cervix; or

 

(g) receiving chronic systemic immunosuppressive drug therapy at the time of the clinical worsening of malignant neoplasm of the cervix; or

 

(h) inability to obtain appropriate clinical management for malignant neoplasm of the cervix.

 

Factors that apply only to material contribution or aggravation

6. Paragraphs 5(f) to 5(h) apply only to material contribution to, or aggravation of, malignant neoplasm of the cervix where the person’s malignant neoplasm of the cervix was suffered or contracted before or during (but not arising out of) the person’s relevant service; paragraph 8(1)(e), 9(1)(e) or 70(5)(d) of the Act refers.

 

Other definitions

7. For the purposes of this Statement of Principles:

 

“being infected with human immunodeficiency virus (HIV)” means serological evidence of infection with human immunodeficiency virus, attracting ICD code 042 or 079.53;

 

“being infected with genital human papilloma virus (HPV)” means clinical, biochemical or molecular evidence of cervical infection with a strain of HPV which causes genital warts, attracting ICD code 078.1.  Infection by HPV can be presumed if a person has had a history of clinical disease caused by HPV or has engaged in sexual activity, where the likelihood of HPV infection was significantly increased (for example, sexual intercourse without barrier protection of the genitals, such as a sheath or condom increases the risk);

 

“chronic systemic immunosuppressive drug therapy” means the therapeutic administration of a drug such as cyclophosphamide, chlorambucil or azathioprine, for organ transplantation;

 

“combined oral contraceptive pill” means a compound containing both oestrogen and progestogen, usually taken in order to block ovulation and prevent the occurrence of pregnancy;

 

“ICD code” means a number assigned to a particular kind of injury or disease in the Australian Version of The International Classification of Diseases, 9th revision, Clinical Modification (ICD-9-CM), effective date of 1 July 1996, copyrighted by the National Coding Centre, Faculty of Health Sciences, University of Sydney, NSW, and having ISBN 0 642 24447 2;

 

“pack-year” means 7 300 cigarettes, or 1 460 cigars, or 7.3kg of pipe tobacco;

 

“relevant service” means:

 

(a) eligible war service (other than operational service); or

(b) defence service (other than hazardous service).

 

 

 

Application

8. This Instrument applies to all matters to which section 120B of the Act applies.

 

 

Dated this Second day of  May 1997

 

 

The Common Seal of the    )

Repatriation Medical Authority   )

was affixed to this instrument  )

in the presence of:    )

KEN DONALD

CHAIRMAN

Overview

The Veterans' Entitlements Act 1986, enacted by the Australian Parliament, aims to provide various benefits and entitlements to veterans and their dependents. In addressing specific medical conditions related to service, the Act enables the establishment and modification of Statements of Principles, which guide the assessment of claims related to particular diseases or injuries. The Repatriation Medical Authority, as part of its function under the Act, issued this legislative instrument to update and clarify the criteria for determining whether malignant neoplasm of the cervix, and death from this condition, can be related to relevant service rendered by veterans. The policy objective here is to ensure that veterans who have developed malignant neoplasm of the cervix, under certain specified conditions, are recognised and supported appropriately. This legislative instrument revokes a previous statement of principles and establishes new criteria for determining the connection between malignant neoplasm of the cervix and relevant service. It outlines the factors that must be present or related to service for the condition to be recognised, such as the use of combined oral contraceptives, smoking history, infection with human papilloma virus or human immunodeficiency virus, immunosuppressive drug therapy, and the inability to obtain appropriate clinical management. The instrument clarifies that certain factors only apply to cases where the malignant neoplasm of the cervix was present before or during service, but not arising out of that service. This legislative update aims to provide clear and medically-supported guidelines for assessing claims related to malignant neoplasm of the cervix in veterans.

Scope and Application

The Revocation and Determination of Statement of Principles concerning Malignant Neoplasm of the Cervix ICD Codes: 180, 233.1, as enacted under the Veterans’ Entitlements Act 1986, pertains to the medical condition of malignant neoplasm of the cervix, including death resulting from this condition, in the context of Australian veterans. The instrument revokes an earlier instrument (No. 128 of 1995) and sets out a new Statement of Principles. This legislative instrument applies to all matters covered by section 120B of the Act, thereby affecting veterans who have served in the Australian Defence Force, encompassing both eligible war service and defence service, excluding hazardous service. The instrument explicitly excludes certain conditions such as soft tissue sarcoma, non-Hodgkin's lymphoma, and Hodgkin's disease from its purview, directing claimants to refer to other relevant Statements of Principles if they wish to claim these conditions. The factors considered in determining the connection between malignant neoplasm of the cervix and relevant service include long-term use of combined oral contraceptives, smoking history, infections with HPV or HIV, and systemic immunosuppressive drug therapy, among others. This legislative instrument operates within the Commonwealth jurisdiction, and its application may be extended or restricted through subordinate instruments, thereby providing a structured framework for veterans' claims related to cervical cancer.

Key Provisions

The main operative sections of this legislative instrument (section 1) revoke Instrument No. 128 of 1995 and establish a new Statement of Principles regarding malignant neoplasm of the cervix and death from malignant neoplasm of the cervix. This statement defines malignant neoplasm of the cervix as a primary invasive carcinoma or carcinoma in situ arising from the cervix uteri, with specific exclusions for certain other diseases (section 2). It also outlines the basis for determining that malignant neoplasm of the cervix can be related to relevant service (section 3), the factors that must be related to service (section 4), and the specific factors that must exist for a connection to be made (section 5). Furthermore, section 6 clarifies the application of certain factors only to material contribution or aggravation of the disease, and section 7 provides definitions for terms used in the Statement of Principles. The obligations imposed by this Act require that the relevant service of veterans or members of the Forces be considered when determining if malignant neoplasm of the cervix or death from the disease is connected to the service (section 1). The Repatriation Medical Authority must assess whether the specified factors, such as the use of combined oral contraceptive pills, smoking, infection with HPV or HIV, immunosuppressive drug therapy, or inability to obtain appropriate clinical management, are related to the person’s relevant service. These factors must be considered in light of the sound medical-scientific evidence available (sections 3-6). There are no explicit offences, penalties, or civil/criminal consequences stated within this instrument for breach of its provisions. However, the determination of the Statement of Principles and the assessment of the factors related to relevant service are critical in the context of veterans' entitlements, and failure to comply with the requirements may impact the eligibility for benefits and compensation related to malignant neoplasm of the cervix under the Veterans’ Entitlements Act 1986.

Legal classification tags

Area of Law
Veterans’ Law
Instrument
Legislative Instrument
Concepts
Definitions & Interpretation
Prohibited Conduct
Enforcement Powers

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.